方形平面铜的抗癌干细胞属性 (II) 复合物与瓦尼林希夫基联体
Yihan Wang1, Kuldip Singh1, Chunxin Lu2
1School of Chemistry, University of Leicester, Leicester LE1 7RH, UK.
Molecules (Basel, Switzerland)
|April 26, 2025
概括
新的铜 (II) 复合物对乳腺癌干细胞 (CSCs) 显示出强烈的活性. 复合物4通过增加活性氧物种和激活关键的亡通路,有效地诱导CSC死亡,提供了一个有前途的新治疗策略.
科学领域:
- 药用化学 医学化学
- 癌症生物学 癌症生物学
- 材料科学 材料科学 材料科学
背景情况:
- 目前的乳腺癌疗法有效性有限,十年死亡率为24%.
- 乳腺癌干细胞 (CSCs) 驱动复发和转移,对死亡率作出重大贡献.
- 氧化还原调节金属复合体提供了一个潜在的策略来准和消除CSCs.
研究的目的:
- 合成和评估新型铜 (II) 复合物与素希夫基联体作为抗乳腺CSC剂.
- 研究这些铜 (II) 复合体与乳腺中枢细胞的结构-活性关系.
- 为了阐明最强大的复合物的作用机制.
主要方法:
- 合成四个铜 (II) 复合体与区域异构瓦尼林希夫基联体.
- 进行X射线晶体学以确定复合体的协调几何.
- 在实验室中对抗乳腺CSC强度和机制性研究 (ROS水平,亡途径) 的评估.
主要成果:
- 合成和特征铜 (II) 复合体1-4 ,展示方形平面几何形状.
- 复合物4对乳腺中枢细胞有显著的功效,其效果优于沙利诺米辛和西斯等现有治疗方法.
- 机械研究表明,复合物4通过高反应性氧物种和JNK/p38通路激活,诱导CSC中的亡.
结论:
- 合成的铜 (II) 复合物代表了一种有前途的新型抗乳腺CSC药物.
- 复合物4表现出卓越的疗效和涉及氧化应激和亡的明确作用机制.
- 这项研究扩大了针对乳腺癌转移和复发的向疗法.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
4.6K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.6K
Drugs that Stabilize Microtubules
1.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
1.9K


